(Q51469783)

5 April 2018

title

Testosterone deficiency and the metabolic syndrome. (English)

1 reference

5 April 2018

1 reference

1 reference

1 reference

Bruno Lunenfeld

1

1 reference

5 April 2018

publication date

1 June 2007

1 reference

5 April 2018

number of pages

4

1 reference

based on heuristic

inferred from page(s)

published in

The Aging Male

1 reference

5 April 2018

volume

10

1 reference

5 April 2018

issue

2

1 reference

5 April 2018

page(s)

53-56

1 reference

5 April 2018

Abdominal obesity and the metabolic syndrome

cites work

1 reference

https://api.crossref.org/works/10.1080%2F13685530701390800

Cardiovascular risk assessment in metabolic syndrome: view from PROCAM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701390800

The role of insulin and the adipocytokines in regulation of vascular endothelial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701390800

Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701390800

In normal men, free fatty acids reduce peripheral but not splanchnic glucose uptake.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701390800

Pancreatic beta-cell lipotoxicity induced by overexpression of hormone-sensitive lipase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701390800

Fatty acids, lipotoxicity and insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701390800

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701390800

Endogenous tissue-type plasminogen activator and risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701390800

Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701390800

Increased plasminogen activator inhibitor type 1 in coronary artery atherectomy specimens from type 2 diabetic compared with nondiabetic patients: a potential factor predisposing to thrombosis and its persistence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701390800

Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701390800

Morbid obesity, hypertensive disease and the renin-angiotensin-aldosterone axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701390800

Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701390800

Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701390800

Cardiovascular risk factors in men: The role of gonadal steroids and sex hormone-binding globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701390800

Relationships between endogenous steroid hormone, sex hormone-binding globulin and lipoprotein levels in men: contribution of visceral obesity, insulin levels and other metabolic variables.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701390800

Sex steroid hormones, upper body obesity, and insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701390800

Prevalence of hypogonadism in males aged at least 45 years: the HIM study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701390800

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701390800

Aromatase, adiposity, aging and disease. The hypogonadal-metabolic-atherogenic-disease and aging connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701390800

The effects of testosterone on insulin sensitivity in male rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701390800

Endogenous sex hormones and metabolic syndrome in aging men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701390800

Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701390800

Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701390800

Decreased testosterone and dehydroepiandrosterone sulfate concentrations are associated with increased insulin and glucose concentrations in nondiabetic men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701390800

Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701390800

Testosterone suppression in men with prostate cancer leads to an increase in arterial stiffness and hyperinsulinaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701390800

Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701390800

Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701390800

Dose-dependent effects of testosterone on regional adipose tissue distribution in healthy young men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701390800

Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701390800

Effects of testosterone on body composition of the aging male

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701390800

Effects of anabolic-androgenic steroid use or gonadal testosterone suppression on serum leptin concentration in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701390800

Sex hormones, body composition and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701390800

10.1080/13685530701390800

21 January 2018

Identifiers

DOI

1 reference

5 April 2018

1 reference

5 April 2018